[Federal Register Volume 74, Number 165 (Thursday, August 27, 2009)]
[Notices]
[Pages 43706-43713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-20634]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0667]
[FDA 09-209-RH-03MOU]
Memorandum of Understanding Between the Food and Drug
Administration, National Center for Toxicological Research, and the Air
Force Research Laboratory, 711 Human Performance Wing, Human
Effectiveness Directorate, Biosciences and Protection Division, for
Toxicity of Nanomaterials
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of
a memorandum of understanding (MOU) between FDA and the Air Force
Research Laboratory. This Memorandum of Understanding (MOU) between the
Food and Drug Administration, National Center for Toxicological
Research (NCTR), and the Air Force Research Laboratory, 711 Human
Performance Wing, Human Effectiveness Directorate, Biosciences and
Protection Division, Applied Biotechnology Branch (711 HPW/RHPB)
(hereinafter referred to as ``the Parties''), sets forth the agreement
of the Parties to facilitate information sharing in the area of
toxicogenomic and computational toxicology research. Through the
exchange of information, the Parties intend to coordinate research
efforts so as to identify and expedite research and development of new
tools and technologies that can be implemented that promote new
understanding of the mechanisms of biological responses to
environmental stressors, including toxic injury, and to identify
biomarkers of exposure and disease that can be used to improve and
protect human health.
DATES: The agreement became effective July 28, 2009.
FOR FURTHER INFORMATION CONTACT:
Points of Contact: The following are Responsible Officers in NCTR and
711 HPW/RHP:
(1) For NCTR: William Slikker, Jr., Director, National Center for
Toxicological Research, Food and Drug Administration, 3900 NCTR Rd.,
Jefferson, AR 72079-9501, phone: 870-543-7950, fax: 870-543-7576, e-
mail: [email protected].
(2) For 711 HPW/RHPB: John J. Schlager, Chief, Applied
Biotechnology Branch, 2729 R St., Wright-Patterson AFB, OH 45433-5707,
phone: 937-904-9570, fax: 937-255-1474, e-mail:
[email protected].
Points of Contact: The following are Principal Investigators in NCTR
and 711 HPW/RHP:
(1) For NCTR: Syed F. Ali, Senior Biomedical Research Scientist,
National Center for Toxicological Research, Food and Drug
Administration, 3900 NCTR Rd., Jefferson, AR 72079-9501, phone: 870-
543-7123, fax: 870-543-7745, e-mail: [email protected].
(2) For 711 HPW/RHPB: Saber M. Hussain, Scientist, Group Lead,
Biological Interaction of Nanomaterials, 2729 R St., Wright-Patterson
AFB, OH 45433-5707, phone: 937-904-9517, fax: 937-904-9610, e-mail:
[email protected].
Points of Contact: The following are points of contact for Agreement
Administration in NCTR and 711 HPW:
(1) For NCTR: Thomas J. Flammang, Deputy Director, Office of
Research, National Center for Toxicological Research, Food and Drug
Administration, 3900 NCTR Rd., Jefferson, AR 72079-9501, phone: 870-
543-7291, fax: 870-543-7576, e-mail: [email protected].
(2) For 711 HPW/XPO: James D. Kearns, Technology Transfer Manager,
2610 Seventh St., Wright-Patterson AFB, OH 45433-7901, phone: 937-255-
3765, fax: 937-255-7215, e-mail: [email protected].
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which
states that all written agreements and MOUs between FDA and others
shall be published in the Federal Register, the agency is publishing
notice of this MOU.
Dated: August 18, 2009.
David Horowitz,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S
[[Page 43707]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.192
[[Page 43708]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.193
[[Page 43709]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.194
[[Page 43710]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.195
[[Page 43711]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.196
[[Page 43712]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.197
[[Page 43713]]
[GRAPHIC] [TIFF OMITTED] TN27AU09.198
[FR Doc. E9-20634 Filed 8-26-09; 8:45 am]
BILLING CODE 4160-01-C